跳至主要内容
临床试验/NCT04863768
NCT04863768Unknown不适用

Molecular Profiling of Colorectal Cancer: A Translational Research Study With a Next Generation Sequencing Panel.

Hellenic Cooperative Oncology Group1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2006年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
association between gene mutational status and overall survival

研究概览

简要总结

In this translational research study, Formalin-Fixed-Paraffin-Embedded (FFPE) tumor tissue blocks from patients with early-stage (II-III) colorectal cancer will be assessed for a comprehensive cancer gene panel from NIPD Genetics (https://www.nipd.com/) targeting regions in 37 clinically relevant cancer genes.

The colorectal cancer panel includes an extended list of clinically relevant genes, designed to target clinically actionable and clinically significant mutations that will provide physicians with genetic information regarding a) prediction of the patient's response to targeted therapy, b) prognosis, that is, prediction of clinical outcome, c) diagnosis and molecular classification of colorectal cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Surgically resected early-stage (II-III) colorectal cancer
  • Availability of biological material

排除标准

  • Metastatic disease (stage IV) at initial diagnosis

结局指标

主要结局

association between gene mutational status and overall survival

时间窗: 24 months

the time from diagnosis to the date of death (from any cause). Alive patients and patients lost to follow-up will be censored at the date of last follow-up

association between gene mutational status and disease-free survival

时间窗: 24 months

the time from colorectal cancer diagnosis to the first date of documented disease progression, death or last contact, whichever occurs first

次要结局

  • Descriptives(24 months)

研究者

发起方
Hellenic Cooperative Oncology Group
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Molecular Profiling of Colorectal Cancer | 临床试验